Literature DB >> 9168404

Impaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individuals.

P J Blair1, L H Boise, S P Perfetto, B L Levine, G McCrary, K F Wagner, D C St Louis, C B Thompson, J N Siegel, C H June.   

Abstract

Progression to AIDS in asymptomatic HIV-infected individuals is characterized by a gradual but progressive loss of CD4+ T cells. While the mechanisms underlying this decline are currently unknown, recent evidence suggests that these cells are abnormally sensitive to apoptosis in response to activation signals. Recent work has implicated downregulation of Bcl-2 with the increased spontaneous apoptosis in lymphocytes from HIV-infected patients. We have evaluated the roles of the apoptosis-protective proteins Bcl-2 and Bcl-x in stimulated PBMC from asymptomatic HIV-infected and HIV-uninfected individuals. We found that Bcl-2 was constitutively expressed in PBMC from both HIV-infected and uninfected samples. However, Bcl-x induction was delayed and responses were decreased in stimulated HIV-infected samples. Additionally, single-cell intracellular staining of Bcl-x revealed a significant inverse correlation between PWM-induced Bcl-x expression and apoptosis (r = -0.695, P = 0.05). This was confirmed at the single-cell level in direct experiments when stimulated cells were sorted based on Bcl-x induction and then measured for apoptosis. Furthermore, low Bcl-x expression was not due to reduced lymphocyte activation following PWM stimulation. Our data indicate that the induction of Bcl-x is markedly impaired in asymptomatic HIV-infected patients and that stimuli which induce inadequate expression of Bcl-x are associated with increased levels of apoptosis in these cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168404     DOI: 10.1023/a:1027310612323

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  61 in total

1.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

Review 2.  The biochemistry of programmed cell death.

Authors:  G Kroemer; P Petit; N Zamzami; J L Vayssière; B Mignotte
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

3.  Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.

Authors:  Z Wang; J G Karras; R G Howard; T L Rothstein
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

Review 4.  The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.

Authors:  R Testi; D D'Ambrosio; R De Maria; A Santoni
Journal:  Immunol Today       Date:  1994-10

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Programmed cell death in AIDS-related HIV and SIV infections.

Authors:  M L Gougeon; S Garcia; J Heeney; R Tschopp; H Lecoeur; D Guetard; V Rame; C Dauguet; L Montagnier
Journal:  AIDS Res Hum Retroviruses       Date:  1993-06       Impact factor: 2.205

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

9.  Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals.

Authors:  N Oyaizu; T W McCloskey; M Coronesi; N Chirmule; V S Kalyanaraman; S Pahwa
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

10.  bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.

Authors:  D A Grillot; R Merino; J C Pena; W C Fanslow; F D Finkelman; C B Thompson; G Nunez
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

2.  CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.

Authors:  P J Blair; J L Riley; D M Harlan; R Abe; D K Tadaki; S C Hoffmann; L White; T Francomano; S J Perfetto; A D Kirk; C H June
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

3.  T-Cell Signaling in HIV-1 Infection.

Authors:  Wasim Abbas; Georges Herbein
Journal:  Open Virol J       Date:  2013-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.